Thomas Rantzau steps down from the Board of Directors at Novo Nordisk A/S after 22 years of employment, with Tanja Villumsen taking his place as employee representative. Novo Nordisk, founded in 1923, is a global healthcare company focused on defeating chronic diseases like diabetes. The company employs around 78,500 people in 80 countries and markets its products in approximately 170 countries. Novo Nordisk’s B shares are listed on Nasdaq Copenhagen, while its ADRs are listed on the New York Stock Exchange. For more information, visit their website or social media platforms.

Read more at GlobeNewswire: New employee representative on the Board of Directors of